CONTRAST - optimized schistosomiasis control and transmission surveillance in Sub-saharan Africa - About CONTRAST
HomeNewsMediaPartnersResearchAboutMisc
Main page arrow About
About CONTRAST

 

Group photo taken at the CONTRAST Kick-off workshop in October 2006
Group photo taken at the CONTRAST Kick-off workshop in October 2006
CONTRAST is a multidisciplinary alliance bringing together key skills and expertise to generate new knowledge on biological, environmental and socio-economic factors relating to schistosomiasis in sub-Saharan Africa. The project will complement ongoing chemotherapy campaigns based on the drug praziquantel and deliver more effective strategies for long-term control of this debilitating disease. The project addresses the basic need of endemic countries to improve understanding of schistosomiasis transmission, in order to target, and make best use of limited resources for control.


CONTRAST will lead to better local control solutions that are more sustainable. Working with European partners (established Research Institutes and a representative from the commercial sector), a strong research node network across sub-Saharan Africa will: establish innovative molecular tools to characterize both snails and schistosomes, define the importance of host-parasite dynamics across different ecological and epidemiological settings, develop new spatial models for disease risk maps and prediction, encourage and assess novel local control interventions using a social science approach and ensure widespread dispersal and access to information. CONTRAST is committed to creating a new and much needed platform for integrated schistosomiasis control in Africa, which will be effective and sustainable at the local, national and regional level.

 

 

Project objectives

It is the overall aim of this project to achieve sustainable schistosomiasis control at the public health level in selected countries in sub-Saharan Africa through development of locally-adapted and appropriate intervention strategies, complementary with ongoing morbidity control using the anthelmintic drug praziquantel (PZQ).
See this page for a detailed breakdown of objectives.

Partners

Id

Partner

Country

1 DBL - Institute for Health Research and Development Denmark
2 Natural History Museum UK
3 Swiss Tropical Institute Switzerland
4 Imperial College London UK
5 Makerere University Uganda
6 University of Zambia
Zambia
7 National Museums of Kenya Kenya
8 Institut Senegalais de Recherches Agricoles Senegal
9 Programme National de la lutte contre la Bilharziose et Geohelminths
Niger
10 Centre for Schistosomiasis and Parasitology Cameroon
11 Ministry of Health- Helminth Control Laboratory Zanzibar
12 National Institute of Medical Research Tanzania
13 Coris Bioconcept
Belgium
14 Ministry of Health-Vector Control Division Uganda